Hims & Hers Health (HIMS) Other Non-Current Liabilities (2020 - 2026)
Hims & Hers Health (HIMS) reported Other Non-Current Liabilities of $12.9 million for Q1 2026, up 428.65% on a YoY basis from $2.4 million in Q1 2025, and up 9.93% sequentially from $11.7 million in Q4 2025.
Hims & Hers Health (HIMS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Other Non-Current Liabilities data on file, last reported at $12.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 428.65% year-over-year to $12.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (up 428.65% YoY), and the FY2025 full-year result was $11.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities rose to $12.9 million in Q1 2026, from $11.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $12.9 million in Q1 2026 to a low of $21000.0 in Q1 2024.
- A 5-year average of $2.8 million and a median of $371000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities plunged 98.45% in 2022 and jumped 11519.05% in 2025, its largest moves.
- Tracing HIMS's Other Non-Current Liabilities over 5 years: stood at $35000.0 in 2022, then tumbled by 37.14% to $22000.0 in 2023, then changed by 0.0% to $22000.0 in 2024, then jumped by 53236.36% to $11.7 million in 2025, then advanced by 9.93% to $12.9 million in 2026.
- Business Quant data shows HIMS's Other Non-Current Liabilities at $12.9 million in Q1 2026, $11.7 million in Q4 2025, and $6.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.90 Mn |
| Dec 31, 2025 | 11.73 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 84,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 249,000.00 |
| Jun 30, 2022 | 371,000.00 |
| Mar 31, 2022 | 517,000.00 |
| Dec 31, 2021 | 629,000.00 |
| Sep 30, 2021 | 11.20 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 33.37 Mn |
| Dec 31, 2020 | 381,000.00 |